U.S. Physical Therapy, Inc. (USPH)

U.S. Physical Therapy Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for U.S. Physical Therapy stock have an average target of 109, with a low estimate of 98 and a high estimate of 115. The average target predicts an increase of 62.01% from the current stock price of 67.28.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$98	$109	$113	$115
Change	+45.66%	+62.01%	+67.95%	+70.93%

* Price targets were last updated on Mar 19, 2025.

Analyst Ratings

The average analyst rating for U.S. Physical Therapy stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	0	1	1	1	1	1
Buy	2	3	3	3	3	3
Hold	1	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Calvin Sternick JP Morgan	JP Morgan	Buy Maintains $120 → $110	Buy	Maintains	$120 → $110	+63.50%	Mar 19, 2025
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $108 → $98	Buy	Maintains	$108 → $98	+45.66%	Feb 28, 2025
Joanna Gajuk B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $100 → $115	Hold → Strong Buy	Upgrades	$100 → $115	+70.93%	Dec 16, 2024
Constantine Davides JMP Securities	JMP Securities	Buy Initiates $113	Buy	Initiates	$113	+67.95%	Dec 16, 2024
Calvin Sternick JP Morgan	JP Morgan	Buy Maintains $117 → $120	Buy	Maintains	$117 → $120	+78.36%	Dec 3, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

766.37M

Increased by 15.34%

from 664.43M

Revenue Next Year

811.68M

Increased by 5.91%

from 766.37M

EPS This Year

2.70

Increased by 46.57%

from 1.84

EPS Next Year

3.02

Increased by 12.10%

from 2.70

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	418.35M	489.72M	547.60M	598.63M	664.43M	766.37M	811.68M	912.80M
Revenue Growth	-12.32%	17.06%	11.82%	9.32%	10.99%	15.34%	5.91%	12.46%
EPS	2.48	2.41	2.25	1.28	1.84	2.70	3.02	3.16
EPS Growth	1.06%	-2.66%	-6.49%	-43.27%	43.97%	46.57%	12.10%	4.55%
Forward PE	-	-	-	-	-	24.94	22.25	21.28
No. Analysts	-	-	-	-	-	9	9	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	811.9M	872.6M	939.7M
Avg	766.4M	811.7M	912.8M
Low	725.1M	764.8M	877.0M

Revenue Growth

Revenue Growth	2025	2026	2027
High	22.2%	13.9%	15.8%
Avg	15.3%	5.9%	12.5%
Low	9.1%	-0.2%	8.0%

EPS Forecast

EPS	2025	2026	2027
High	3.36	3.91	3.26
Avg	2.70	3.02	3.16
Low	2.13	2.36	3.04

EPS Growth

EPS Growth	2025	2026	2027
High	82.5%	44.8%	7.6%
Avg	46.6%	12.1%	4.6%
Low	15.5%	-12.5%	0.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.